Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 7: 46146, 2017 04 10.
Artículo en Inglés | MEDLINE | ID: mdl-28393852

RESUMEN

Epidemiologic studies showed the correlation between the deficiency of omega-3 polyunsaturated fatty acids (n-3 PUFAs) and the progression of chronic kidney diseases (CKD), however, the role and mechanisms for n-3 PUFAs in protecting against kidney fibrosis remain obscure. In this study, NRK-49F cells, a rat kidney interstitial fibroblast cell line, were stimulated with TGFß1. A Caenorhabditis elegans fat-1 transgenic mouse model in which n-3 PUFAs are endogenously produced from n-6 PUFAs owing to the expression of n-3 fatty acid desaturase were deployed. Docosahexaenoic acid (DHA), one member of n-3 PUFAs family, could suppress TGFß1-induced fibroblast activation at a dose and time dependent manner. Additionally, DHA could largely inhibit TGFß1-stimulated Akt but not S6 or Smad3 phosphorylation at a time dependent manner. To decipher the role for n-3 PUFAs in protecting against kidney fibrosis, fat-1 transgenic mice were operated with unilateral ureter obstruction (UUO). Compared to the wild types, fat-1 transgenics developed much less kidney fibrosis and inflammatory cell accumulation accompanied by less p-Akt (Ser473), p-Akt (Thr308), p-S6 and p-Smad3 in kidney tissues at day 7 after UUO. Thus, n-3 PUFAs can attenuate fibroblast activation and kidney fibrosis, which may be associated with the inhibition of mTORC2 signaling.


Asunto(s)
Ácidos Grasos Omega-3/farmacología , Fibroblastos/patología , Riñón/patología , Diana Mecanicista del Complejo 2 de la Rapamicina/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/genética , Línea Celular , Matriz Extracelular/metabolismo , Ácido Graso Desaturasas/genética , Ácidos Grasos Omega-3/uso terapéutico , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibrosis , Inflamación/patología , Enfermedades Renales/patología , Enfermedades Renales/terapia , Ratones Endogámicos C57BL , Ratones Transgénicos , Fosforilación/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Factor de Crecimiento Transformador beta1/farmacología , Transgenes , Obstrucción Ureteral/tratamiento farmacológico , Obstrucción Ureteral/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA